Real-World Cost Per Persisting Patient- Comparing Psoriasis Patients Initiated on Apremilast or Biologic Therapies
May 1, 2016, 00:00
10.1016/j.jval.2016.03.512
https://www.valueinhealthjournal.com/article/S1098-3015(16)00580-5/fulltext
Title :
Real-World Cost Per Persisting Patient- Comparing Psoriasis Patients Initiated on Apremilast or Biologic Therapies
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)00580-5&doi=10.1016/j.jval.2016.03.512
First page :
A125
Section Title :
Sensory System Disorders - Patient-Reported Outcomes & Patient Preference Studies
Open access? :
No
Section Order :
161